IP Verse

Curevac competitive analysis

Latest publications and patents of Curevac New

Explore the latest publications and patents granted to Curevac, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Curevac

EP3283059
Jan 3, 2024Method For Producing Rna CompositionsGranted And Under Opposition
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna MoleculeGranted And Under Opposition
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationGranted And Under Opposition
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein ExpressionGranted And Under Opposition
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna ProductionRevoked
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein ExpressionGranted And Under Opposition
EP3283125
Dec 29, 2021Lyophilization Of RnaGranted And Under Opposition
EP3115064
Nov 24, 2021Rna-Coded AntibodyGranted And Under Opposition
EP2680880
Nov 10, 2021Vaccination In Newborns And InfantsPatent Maintained As Amended
EP3298142
Jul 14, 2021Dry Powder Composition Comprising Long-Chain RnaGranted And Under Opposition

Latest patents of Curevac opposed by its competitors

Explore Curevac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3283059
Jan 3, 2024Method For Producing Rna Compositions7
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna Molecule4
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration5
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna Production3
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3283125
Dec 29, 2021Lyophilization Of Rna2
EP3115064
Nov 24, 2021Rna-Coded Antibody1
EP2680880
Nov 10, 2021Vaccination In Newborns And Infants1
EP3297682
Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2

Latest PTAB cases involving Curevac

Discover the latest PTAB cases involving Curevac, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Curevac

IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision
IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Curevac with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CUREVAC - 62 - 1Non-Active
BIONTECH3061 - Highly Aggressive
SANOFI5923 - - Highly Aggressive
STRAWMAN331 - - - Highly Aggressive